医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
ACRV · Acrivon Therapeutics, Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Acrivon Therapeutics, Inc.（ACRV）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $40K；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-07。
买入 Bought—
卖出 Sold$40K
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-05 | Miller Mary Chief Legal Officer | 卖出 Sell | 294 | $1.99 | $585 | SEC |
| 2026-08-25 | Blume-Jensen Peter Director, EVP - Business Operations, President and CEO | 卖出 Sell | 14,036 | $2.21 | $31K | SEC |
| 2026-08-18 | Blume-Jensen Peter Director, EVP - Business Operations, President and CEO | 卖出 Sell | 1,713 | $2.01 | $3K | SEC |
| 2026-08-18 | Devroe Eric Chief Operating Officer | 卖出 Sell | 604 | $2.01 | $1K | SEC |
| 2026-08-18 | Gamelin Erick Chief Development Officer | 卖出 Sell | 400 | $2.01 | $804 | SEC |
| 2026-08-18 | Miller Mary Chief Legal Officer | 卖出 Sell | 185 | $2.01 | $372 | SEC |
| 2026-08-18 | Peterson Katharine Chief Accounting Officer | 卖出 Sell | 101 | $2.01 | $203 | SEC |
| 2026-08-04 | Levy Adam D. Chief Financial Officer | 卖出 Sell | 1,142 | $1.57 | $2K | SEC |
| 2026-07-21 | Miller Mary Chief Legal Officer | 卖出 Sell | 573 | $1.76 | $1K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-08-25 | Blume-Jensen Peter Officer, Director | 14,036 | $31K |
内部人 Insiders
Miller Mary、Blume-Jensen Peter、Devroe Eric、Gamelin Erick、Peterson Katharine、Levy Adam D.